Notification of Transactions of Directors and Persons Discharging Managerial Responsibility
GlaxoSmithKline Share Value Plan
Sale of shares to meet tax liabilities
The table below sets out changes in the interests of Persons Discharging Managerial Responsibility (PDMR) in the Ordinary Shares of GlaxoSmithKline plc arising from the sales of Ordinary Shares at a fair market value price of £15.353625 per Ordinary Share on 18 February 2015. These sales were to meet tax liabilities following the vesting of awards granted in 2012 under the GlaxoSmithKline Share Value Plan (SVP).
|
Number of Ordinary Shares sold to meet tax liabilities following the vesting of a SVP award |
Mr R Connor |
8,423 |
Mrs V Whyte |
6,143 |
The table below sets out changes in the interests of a PDMR in the American Depositary Shares (ADS) of GlaxoSmithKline plc arising from the withholding of ADS at a fair market value price of $47.94 per ADS on 18 February 2015 to meet tax liabilities following the vesting of awards granted in 2012 under the SVP.
|
Number of ADSs withheld to meet tax liabilities following the vesting of a SVP award |
Mr N Hirons |
1,891 |
The Company and PDMRs were advised of these transactions on 19 February 2015.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
19 February 2015